News13/03/2024Antheia and Olon Continue Partnership for Biomanufacturing Antheia’s Pipeline of KSMs and APIs for Essential Medicines
News06/03/2024Olon will be supplying Epinephrine, crucial API for life saving treatments, listed in major international drug shortage databases such as those maintained by regulatory bodies like EMA and FDA
News15/01/2024Olon Group discloses that, as of January 1, 2024, Olon Ricerca Bioscience LLC, Concord, OH and Olon USA Inc. commercial offices, based in Florham Park, NJ, have merged to become Olon USA LLC.
Focus26/11/2023CASE STUDY: Nucleophilic substitution of the nitro group in aromatic compound in flow conditions (V.Anzi)
News21/11/2023OLON OFFICIALLY OPENS ITS NEW RESEARCH AND DEVELOPMENT CENTRE, CORNERSTONE OF ITS GLOBAL R&D NETWORK
News18/10/2023CPhI Worldwide 2023 Olon Announces a Further Significant Expansion of its Generic Pipelines
